Overview: Hugel, Inc. is a company that develops and manufactures biopharmaceuticals in South Korea and internationally, with a market cap of ₩2.97 trillion. Operations: The company generates revenue ...
As global markets navigate a period of mixed performance, with the Nasdaq Composite reaching new heights while other major indexes face declines, investors are keenly observing central bank actions ...